Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients
Georgy Berezhnoy, Rosi Bissinger, Anna Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25

Showing 25 citing articles:

Integration of metabolomics methodologies for the development of predictive models for mortality risk in elderly patients with severe COVID-19
Shanpeng Cui, Qiuyuan Han, Ran Zhang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients Using a Multiplatform Mass Spectrometry-Based Metabolomics Approach
Sara Martínez, Oihane E. Albóniga, María Rosa López‐Huertas, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 3025-3040
Closed Access | Times Cited: 5
Blood Biomarkers of Long COVID: A Systematic Review
Callum Thomas, Mark A. Faghy, Corinna Chidley, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 5, pp. 537-574
Closed Access | Times Cited: 5
Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome
Simon Haunhorst, Diana Dudziak, Carmen Scheibenbogen, et al.
Infection (2024)
Open Access | Times Cited: 5
Long COVID: An approach to clinical assessment and management in primary care
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo
South African Family Practice (2023) Vol. 65, Iss. 1
Open Access | Times Cited: 11
Longitudinal NMR-Based Metabolomics Study Reveals How Hospitalized COVID-19 Patients Recover: Evidence of Dyslipidemia and Energy Metabolism Dysregulation
Laura Ansone, Vita Rovīte, Monta Brīvība, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1523-1523
Open Access | Times Cited: 4
Immune activation and immune-associated neurotoxicity in Long-COVID: A systematic review and meta-analysis of 103 studies comprising 58 cytokines/chemokines/growth factors
Abbas F. Almulla, Yanin Thipakorn, Bo Zhou, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 75-94
Open Access | Times Cited: 4
Lipidomic and Metabolomic Changes in Community-acquired and COVID-19 Pneumonia
Mireia Saballs, Sandra Parra, N. Martínez, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 9, pp. 100622-100622
Open Access | Times Cited: 4
Síntomas prevalentes y características de la población en la COVID prolongada: una revisión de alcance
Karina Marques Prediger, Ana Cristina Ribeiro, Sílvia Carla da Silva André Uehara
Revista Latino-Americana de Enfermagem (2025) Vol. 33
Open Access
Sintomas prevalentes e características da população na COVID Longa: uma revisão de escopo
Karina Marques Prediger, Ana Cristina Ribeiro, Sílvia Carla da Silva André Uehara
Revista Latino-Americana de Enfermagem (2025) Vol. 33
Open Access
Prevalent symptoms and characteristics of the Long COVID-19 population: a scoping review
Karina Marques Prediger, Ana Cristina Ribeiro, Sílvia Carla da Silva André Uehara
Revista Latino-Americana de Enfermagem (2025) Vol. 33
Open Access
Alterations in Gut Microbiome Composition and Increased Inflammatory Markers in Post-COVID-19 Individuals
Tatiana Barichello, Bruno Kluwe‐Schiavon, Laura A. Borba, et al.
Molecular Neurobiology (2025)
Closed Access
The Omics Landscape of Long COVID—A Comprehensive Systematic Review to Advance Biomarker, Target and Drug Discovery
Nadia Baalbaki, Elise M. A. Slob, Samuel W. Kazer, et al.
Allergy (2025)
Open Access
Lipoprotein (a) as a predictor of the possibility of multifocal atherosclerosis in patients with stable CHD in the post-COVID period
D. A. Yakhontov, D.A. Derisheva
Ateroscleroz (2025) Vol. 21, Iss. 1, pp. 34-48
Open Access
Acute and Chronic Post-COVID-19 Conditions: A Study of Genetic Integrity and Clinical Markers
Bruna Alves Alonso Martins, Ana Letícia Hilário Garcia, Malu Siqueira Borges, et al.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2025) Vol. 904, pp. 503870-503870
Closed Access
Blood proteomics in COVID-19 infection: An update
Michal Alexovič, Tetiana Bondarchuk, Csilla Uličná, et al.
Clinica Chimica Acta (2024) Vol. 562, pp. 119881-119881
Closed Access | Times Cited: 3
Long COVID and gut candidiasis: What is the existing relationship?
Filippo Bistagnino, Davide Pizzi, Filippo Mantovani, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 37, pp. 4104-4114
Closed Access | Times Cited: 2
Immune activation and immune-associated neurotoxicity in Long-COVID: A systematic review and meta-analysis of 82 studies comprising 58 cytokines/chemokines/growth factors
Abbas F. Almulla, Yanin Thipakorn, Bo Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Quantitative Metabolomics and Lipoprotein Analysis of PDAC Patients Suggests Serum Marker Categories for Pancreatic Function, Pancreatectomy, Cancer Metabolism, and Systemic Disturbances
Gyuntae Bae, Georgy Berezhnoy, Alejandra Flores, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 4, pp. 1249-1262
Open Access | Times Cited: 1
Mendelian randomization study on the association of circulating ketone bodies with lung cancer and respiratory diseases
Xisha Tang, Huijia Zhuang, Hai Yu
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Proteomic and metabolomic profiling of plasma uncovers immune responses in patients with Long COVID-19
Yulin Wei, Hongyan Gu, Jun Ma, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019
Feixiang Yang, Peng Guo, Kun Wang, et al.
Prostate International (2024) Vol. 12, Iss. 3, pp. 167-177
Open Access
Quantitative Blood Serum IVDr NMR Spectroscopy in Clinical Metabolomics of Cancer, Neurodegeneration, and Internal Medicine
Christoph Trautwein
Methods in molecular biology (2024), pp. 427-443
Closed Access
Salivary Metabolomics in Patients with Long COVID-19 Infection
Luiz Henrique Soares Machado, Robson Prudente, Estefânia Franco, et al.
Metabolites (2024) Vol. 14, Iss. 11, pp. 598-598
Open Access
Longitudinal NMR-Based Metabolomics Study Reveals How Hospitalized COVID-19 Patients Recover: Evidence of Dyslipidemia and Energy Metabolism Dysregulation
Laura Ansone, Vita Rovīte, Monta Brīvība, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top